XCUR Return on Tangible Equity | EXICURE, INC.

EXICURE, INC. (XCUR) Return on Tangible Equity

2026-06-30: Return Tang Equity 242.08%.
2026-03-31: Return Tang Equity 425.21%.
2025-12-31: Return Tang Equity 1045.67%.
2025-09-30: Return Tang Equity -257.29%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	242.08%
2026-03-31	425.21%
2025-12-31	1045.67%
2025-09-30	-257.29%
2025-06-30	-142.73%
2025-03-31	-72.89%
2024-12-31	-143.25%
2024-09-30	-259.35%
2024-06-30	-506.63%
2024-03-31	-604.26%
2023-12-31	-558.03%
2023-09-30	66.01%
2023-06-30	31.58%
2023-03-31	9.30%
2022-12-31	-17.30%
2022-09-30	939.86%
2022-06-30	-4572.14%
2022-03-31	-1853.31%
2021-12-31	-570.71%
2021-09-30	-450.28%
2021-06-30	-131.69%
2021-03-31	-76.53%
2020-12-31	-40.11%
2020-09-30	-29.91%
2020-06-30	-23.19%
2020-03-31	-23.34%
2019-12-31	-32.57%
2019-09-30	-32.45%
2019-06-30	-180.71%
2019-03-31	-137.36%
2018-12-31	-106.97%
2018-09-30	-83.74%
2018-06-30	-178.84%
2018-03-31	-66.82%
2017-12-31	-41.91%
2017-09-30	-42.34%
2017-08-31	21662.74%
2017-05-31	58802.14%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	1045.67%
2024-12-31	-143.25%
2023-12-31	-558.03%
2022-12-31	-17.30%
2021-12-31	-570.71%
2020-12-31	-40.11%
2019-12-31	-32.57%
2018-12-31	-106.97%
2017-12-31	-55.12%
2016-12-31	-692.03%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SOLIGENIX, INC. (SNGX)	United States	$0.008B
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Traws Pharma, Inc. (TRAW)	United States	$0.009B	-0.58
Alzamend Neuro, Inc. (ALZN)	United States	$0.009B
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
FibroBiologics, Inc. (FBLG)	United States	$0.009B	-0.27